Literature DB >> 9507832

Transvaginal urethrolysis for urethral obstruction after anti-incontinence surgery.

C A Cross1, R D Cespedes, S F English, E J McGuire.   

Abstract

PURPOSE: Urethral obstruction following a stress incontinence procedure occurs in 5 to 20% of patients. We examine the success of transvaginal urethrolysis in resolving voiding dysfunction.
MATERIALS AND METHODS: A retrospective chart review was performed on 39 patients who had undergone transvaginal urethrolysis for urethral obstruction following an anti-incontinence procedure. Preoperatively, a history was taken, and pelvic examination and either video urodynamics or cystoscopy were done.
RESULTS: All 39 patients complained of urge incontinence, 13% had urinary retention, 51% had incomplete bladder emptying and 36% voided to completion but had irritative voiding symptoms. Previous surgery included retropubic urethropexy in 41% of the cases, pubovaginal sling in 38% and bladder neck suspension in 21%. Mean length of followup after urethrolysis was 16 months. Of the 39 patients 33 (85%) had resolution of urge incontinence but 5 still required occasional intermittent catheterization. The remaining 6 patients had continued urge incontinence. An augmentation procedure was performed in 4 patients with improvement of symptoms.
CONCLUSIONS: Our data support transvaginal urethrolysis for the treatment of iatrogenic urethral obstruction. It is a rapid, effective and minimally invasive technique that should be considered if voiding dysfunction does not resolve spontaneously.

Entities:  

Mesh:

Year:  1998        PMID: 9507832

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Voiding dysfunction after surgery for stress incontinence: literature review and survey results.

Authors:  James S Dunn; Alfred E Bent; R Mark Ellerkman; Mikio A Nihira; Clifford F Melick
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-12-19

2.  Correlation of introital ultrasound with LUTS after sling surgery.

Authors:  Pascal Mouracade; Sawsan El Abiad; Catherine Roy; Herve Lang; Didier Jacqmin; Christian Saussine
Journal:  Int Urogynecol J       Date:  2010-07-01       Impact factor: 2.894

3.  Various surgical approaches to treat voiding dysfunction following anti-incontinence surgery.

Authors:  Jeffrey Segal; Andrew Steele; Brett Vassallo; Steven Kleeman; Andre W Silva; Rachel Pauls; Peggy Walsh; Mickey Karram
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-01-21

4.  Transvaginal urethrolysis for obstruction after antiincontinence surgery.

Authors:  Rebecca McCrery; Rodney Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-10-12

Review 5.  Managing women with complex presentations: How to approach concomitant prolapse and voiding dysfunction.

Authors:  Cornelius Kelleher
Journal:  Can Urol Assoc J       Date:  2013-09       Impact factor: 1.862

6.  Obstruction after Burch colposuspension: a return to retropubic urethrolysis.

Authors:  Jennifer T Anger; Cindy L Amundsen; George D Webster
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-11-10

Review 7.  Bladder outlet obstruction in women: iatrogenic, anatomic, and neurogenic.

Authors:  Rebecca J McCrery; Rodney A Appell
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 3.092

8.  Transvaginal tape lysis for urinary obstruction after suburethral tape placement. When to do an immediate replacement?

Authors:  Pascal Mouracade; Herve Lang; Didier Jacqmin; Christian Saussine
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-05-07

Review 9.  Methods and results of urethrolysis.

Authors:  Jonathan S Starkman; Harriette Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

Review 10.  Management of urinary retention and obstruction following surgery for stress urinary incontinence.

Authors:  Harriette M Scarpero; Victor W Nitti
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 2.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.